Global COVID-19 Advice for People with Multiple Sclerosis

COVID-19 is a new illness that can affect your lungs and airways. It is caused by a novel coronavirus that was first detected in people in China in December 2019 and has since spread to other parts of the world.

 

There is currently no evidence on how COVID-19 affects people with multiple sclerosis (MS). The advice below was developed by MS neurologists* and research experts from MSIF’s member organisations**.

 

This advice will be reviewed and updated as evidence about COVID-19 becomes available.

ABN Guidance on the Use of DMTs in MS in Response to the Threat of a Coronavirus Pandemic

We have drafted our recommendations in two forms, one suitable for health professionals and another suitable for people with multiple sclerosis.